Trial NCT00459108

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2009-00224
Secondary IDs: 7792 CDR0000538220 N01CM62201 N01CM62209 NCI-2009-00224 PHII-83

Last trial update was posted on 2018-04-19

MeSH Interventions

Dasatinib

MeSH Conditions

Carcinoma Carcinoma, Hepatocellular Liver Neoplasms

Other Conditions

Adult Primary Hepatocellular Carcinoma Advanced Adult Primary Liver Cancer Recurrent Adult Primary Liver Cancer

Stopping Reasons

Halted early for futility.

Limitations And Caveats

Study was terminated early after the first stage of a two-stage design, allowing for early termination for discouraging results.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID